Adjuvant Therapy of Colorectal Cancer: Why We Still Don’t Know

JAMA: The Journal of the American Medical Association

Volumn 259, Issue 24, 1988, Pages 3571-3578

  Buyse, Marc ^a,c   Zeleniuch Jacquotte, Anne ^b   Chalmers, Thomas C ^a,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c European Organization for Research   (Belgium)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; FLUOROURACIL; LEVAMISOLE; MITOMYCIN C; SEMUSTINE;

COLORECTAL CANCER; CONTROLLED STUDY; CORYNEBACTERIUM PARVUM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOTHERAPY; REVIEW;

CLINICAL TRIALS; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMAN; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECTAL NEOPLASMS; RESEARCH DESIGN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023887810     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03720240033031     Document Type: Article

References (43)

1. 1986 Cancer Facts & Figures. New York, American Cancer Society, 1987.
2. Reitemeier RJ: Current status of chemotherapy in the management of patients with advanced gastrointestinal adenocarcinoma. Curr Concepts Gastroenterol 1976;1:31-36.
3. Gilbert JM: Adjuvant chemotherapy of large-bowel cancer. Cancer Treat Rev 1982;9:195-228.
4. Higgins GA: Current status of adjuvant therapy in the treatment of large-bowel cancer. Surg Clin North Am 1983;63:137-150.
5. Wilson RE: Adjuvant therapy for colorectal cancer. Ann Chir Gynaecol 1983;72:290-292.
6. MacDonald JS: The immunobiology of colorectal cancer. Semin Oncol 1976;3:421-431.
7. Carter SK: Current protocol approaches in large-bowel cancer. Semin Oncol 1976;3:433-443.
8. Davis HL, Kisner DL: Analysis of adjuvant therapy in large-bowel cancer. Cancer Clin Trials 1978;9:273-287.
9. Decosse JJ: Are we doing better with large-bowel cancer? N Engl J Med 1984;310:782-783.
10. Adjuvant treatment of carcinoma of the rectum and colon, editorial. Lancet 1985;2:367-368.
11. Heald RJ: Adjuvant treatment of carcinoma of the rectum and colon. Lancet 1985;2:559.
12. Kligerman MM: Radiation therapy for rectal carcinoma. Semin Oncol 1976;3:407-413.
13. Priestman TJ: The place of radiation therapy in the management of rectal adenocarcinoma. Cancer Treat Rev 1977;4:1-12.
14. Higgins GA: Adjuvant radiation therapy in colon cancer. Int Adv Surg Oncol 1979;2:1-24.
15. Sischy B: The place of radiotherapy in the management of rectal adenocarcinoma. Cancer 1982;50:2631-2637.
16. Wooley PV, MacDonald JS, Schein PS: Chemotherapy of colorectal carcinoma. Semin Oncol 1976;3:415-420.
17. Moertel CG: Fluorouracil as an adjuvant to colorectal cancer surgery: The breakthrough that never was. JAMA 1976;236:1935-1936.
18. Moertel CG: Chemotherapy of gastrointestinal cancer. N Engl J Med 1978;299:1049-1052.
19. Valdivieso M, Maviglit GM: Chemotherapy and chemoimmunotherapy of colorectal cancer: Role of the carcinoembryonic antigen. Surg Clin North Am 1978;58:619-631.
20. Wolmark N: Adjuvant chemotherapy in colorectal cancer. Can J Surg 1985;28:416-419.
21. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 1959;22:719-748.
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
23. DerSimonian R, Laird NM: Meta-analysis in clinical trials. Controlled Clin Trials 1986;7:177-188.
24. Yusuf S, Peto R, Lewis J, et al.: Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-371.
25. Gail M, Simon R: Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985;41:361-372.
26. Freiman JA, Chalmers TC, Smith H Jr, et al.: The importance of beta, the type II error, and sample size in the design and interpretation of the randomized control trial: Survey of 71 ’negative’ trials. N Engl J Med 1978;299:690-694.
27. Yusuf S, Collins R, Peto R: Why do we need some large, simple randomized trials? Stat Med 1984;3:409-420.
28. George SL: The required sample size and length of a phase III clinical trial, in Buyse M, Staquet M, Sylvester R (eds): Cancer Clinical Trials: Methods and Practice. New York, Oxford University Press Inc, 1984, pp 287-310.
29. Light RJ, Pillemer DB: Summing Up: The Science of Reviewing Research. Cambridge, Mass, Harvard University Press, 1984.
30. Krook J, Moertel C, Wieand H, et al.: Radiation vs sequential chemotherapy radiation-chemotherapy: A study of the North Central Cancer Treatment Group, abstracted. Proc Am Soc Clin Oncol 1986;5:82.
31. Wolmark N, Fisher B, Rockette H, et al.: Adjuvant therapy in carcinoma of the colon: Five-year results of NSABP protocol C-01, in Jones SE, Salmon SE (ed): Adjuvant Therapy of Cancer. New York, Grune & Stratton, 1987, p 63, abstract 72.
32. Panettiere FJ, Chen T: The SWOG large-bowel adjuvant study suggests benefits from therapy. Proc Am Soc Clin Oncol 1985;4:76.
33. Laurie J, Moertel C, Fleming T, et al.: Surgical adjuvant therapy of poor-prognosis colorectal cancer with levamisole alone or combined levamisole and 5-fluorouracil: A North Central Cancer Treatment Group and Mayo Clinic Study. Proc Am Soc Clin Oncol 1986;5:81.
34. Sterling TD: Publication decisions and their possible effects on inferences drawn from tests of significance or vice versa. J Am Stat Assoc 1959;54:31-34.
35. Begg CB: A measure to aid the interpretation of published clinical trials. Stat Med 1985;4:1-10.
36. Juhl E, Christensen E, Tygstrup N: The epidemiology of the gastrointestinal clinical trial. N Engl J Med 1977;296:20-22.
37. Chan SS, Sacks HS, Chalmers TC: The epidemiology of unpublished randomized control trials, abstracted. Clin Res 1982;30:234.
38. Simes RJ: Publication bias: The case for an international registry of clinical trials. J Clin Oncol 1986;4:1529-1542.
39. Fisher B, Wolmark N, Rockette H, et al.: Adjuvant chemotherapy or postoperative radiation for rectal cancer: Five-year results of NSABP R-01, in Jones SE, Salmon SE (eds): Adjuvant Therapy of Cancer. New York, Grune & Stratton, 1987, p 63, abstract 71.
40. Hojo K, Kajitani T, Kusama S, et al.: Adjuvant Therapy for Colorectal Cancer: Cooperative Study Group for Colorectal Cancer in Japan, abstract 1183. Programs and abstracts of the Proceedings of the Seventh Gastroenterology World Congress, Stockholm, June 14-19, 1982, p 298.
41. Buyse M, Ryan L: Issues of efficiency in combining proportions of deaths from several clinical trials. Stat Med 1987;6:565-576.
42. Peto R: Statistical aspects of cancer trials, in Halnan KE (ed): Treatment of Cancer. New York, Chapman & Hall, 1982, pp 867-871.
43. Sacks HS, Berrier J, Reitman D, et al.: Metaanalyses of randomized controlled trials. N Engl J Med 1987;316:450-455.